233 related articles for article (PubMed ID: 15800924)
1. CYP19 (aromatase) haplotypes and endometrial cancer risk.
Paynter RA; Hankinson SE; Colditz GA; Kraft P; Hunter DJ; De Vivo I
Int J Cancer; 2005 Aug; 116(2):267-74. PubMed ID: 15800924
[TBL] [Abstract][Full Text] [Related]
2. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.
Haiman CA; Hankinson SE; Spiegelman D; De Vivo I; Colditz GA; Willett WC; Speizer FE; Hunter DJ
Int J Cancer; 2000 Jul; 87(2):204-10. PubMed ID: 10861475
[TBL] [Abstract][Full Text] [Related]
3. Effect of CYP19 rs6493497 and rs7176005 haplotype status on in vivo aromatase transcription, plasma and tissue estrogen levels in postmenopausal women.
Straume AH; Knappskog S; Lønning PE
J Steroid Biochem Mol Biol; 2012 Jan; 128(1-2):69-75. PubMed ID: 21939764
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
[TBL] [Abstract][Full Text] [Related]
5. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
[TBL] [Abstract][Full Text] [Related]
6. [A polymorphism study of the CYP19 gene in endometrial cancer patients].
Bershteĭn LM; Imianitov EN; Suspitsyn EN; Grigor'ev MIu; Sokolov EP; Togo AV; Khanson KP; Poroshina TE; Gamaiunova VB; Vasil'ev DA; Kovalevskiĭ AIu; Volkov ON
Vopr Onkol; 2000; 46(3):302-5. PubMed ID: 10976276
[TBL] [Abstract][Full Text] [Related]
7. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity.
Berstein LM; Imyanitov EN; Kovalevskij AJ; Maximov SJ; Vasilyev DA; Buslov KG; Sokolenko AP; Iyevleva AG; Chekmariova EV; Thijssen JH
Cancer Lett; 2004 Apr; 207(2):191-6. PubMed ID: 15072828
[TBL] [Abstract][Full Text] [Related]
8. The T/C polymorphism of the CYP17 gene and G/A polymorphism of the CYP19 gene in endometrial cancer.
Szyllo K; Smolarz B; Romanowicz-Makowska H; Lewy J; Kulig B
J Exp Clin Cancer Res; 2006 Sep; 25(3):411-6. PubMed ID: 17167982
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
[TBL] [Abstract][Full Text] [Related]
10. The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.
Kim JY; Lee CS; Kim HO; Jo YH; Lee J; Jung MH; Baik HH; Choe W; Kang I; Yoon KS
Oncol Rep; 2009 Sep; 22(3):487-92. PubMed ID: 19639193
[TBL] [Abstract][Full Text] [Related]
11. A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.
Talbott KE; Gammon MD; Kibriya MG; Chen Y; Teitelbaum SL; Long CM; Gurvich I; Santella RM; Ahsan H
Breast Cancer Res Treat; 2008 Oct; 111(3):481-7. PubMed ID: 17975727
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.
Tao MH; Cai Q; Zhang ZF; Xu WH; Kataoka N; Wen W; Xiang YB; Zheng W; Shu XO
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):943-9. PubMed ID: 17507620
[TBL] [Abstract][Full Text] [Related]
14. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review.
Olson SH; Bandera EV; Orlow I
Am J Epidemiol; 2007 Feb; 165(3):235-45. PubMed ID: 17110639
[TBL] [Abstract][Full Text] [Related]
15. The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients.
Szyłło K; Smolarz B; Romanowicz-Makowska H; Kulig A
Pol J Pathol; 2006; 57(1):35-40. PubMed ID: 16739881
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches.
Olson JE; Ingle JN; Ma CX; Pelleymounter LL; Schaid DJ; Pankratz VS; Vierkant RA; Fredericksen ZS; Wu Y; Couch FJ; Vachon CM; Sellers TA; Weinshilboum RM
Breast Cancer Res Treat; 2007 Apr; 102(2):237-47. PubMed ID: 17004113
[TBL] [Abstract][Full Text] [Related]
17. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism.
Gennari L; Masi L; Merlotti D; Picariello L; Falchetti A; Tanini A; Mavilia C; Del Monte F; Gonnelli S; Lucani B; Gennari C; Brandi ML
J Clin Endocrinol Metab; 2004 Jun; 89(6):2803-10. PubMed ID: 15181061
[TBL] [Abstract][Full Text] [Related]
18. Interaction between CYP19A1 polymorphisms and body mass index in the risk of endometrial cancer in postmenopausal Japanese women.
Hosono S; Matsuo K; Ito H; Watanabe M; Hirose K; Nakanishi T; Tajima K; Tanaka H
Asian Pac J Cancer Prev; 2011; 12(10):2747-52. PubMed ID: 22320986
[TBL] [Abstract][Full Text] [Related]
19. CYP19 gene polymorphism in endometrial cancer patients.
Berstein LM; Imyanitov EN; Suspitsin EN; Grigoriev MY; Sokolov EP; Togo A; Hanson KP; Poroshina TE; Vasiljev DA; Kovalevskij AY; Gamajunova VB
J Cancer Res Clin Oncol; 2001 Feb; 127(2):135-8. PubMed ID: 11216915
[TBL] [Abstract][Full Text] [Related]
20. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women.
Baghaei F; Rosmond R; Westberg L; Hellstrand M; Eriksson E; Holm G; Björntorp P
Obes Res; 2003 Apr; 11(4):578-85. PubMed ID: 12690088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
